Phase Two Ventures

Phase Two Ventures is a seed-stage venture capital firm headquartered in San Diego, specializing in early-stage investments within the life sciences sector. The firm focuses on identifying and supporting startups that develop essential R&D tools, platform technologies, and computational biology solutions. With a mission to drive the next generation of basic research, diagnostics, and therapeutics, the firm targets technical founders with expertise in areas such as multi-omics, bioengineering, synthetic biology, and cell and gene therapies. Their investment strategy is led by co-founders who leverage years of operational experience to provide more than just capital; they actively engage with founders through coaching and strategic support to help navigate the complexities of commercializing early-stage scientific technology.

The firm's approach is designed to translate innovative research into viable commercial successes, which is particularly critical for startups in the highly specialized biotech and healthcare industries. By offering pre-seed and seed-stage funding, typically ranging from $100K to $500K, Phase Two Ventures addresses the needs of early-stage entrepreneurs who require both financial backing and domain-specific guidance to reach their next development milestones. This hands-on involvement includes providing strategic connections within the broader biotech ecosystem, which helps portfolio companies bridge the gap between initial discovery and market adoption. Their track record includes support for various companies in fields like diagnostics and digital health, demonstrating a consistent focus on backing innovations that solve significant technical bottlenecks in scientific research.